Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Apr 15, 2025; 16(4): 103546
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.103546
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.103546
Jejunoileal side-to-side anastomosis as a promising option for type 2 diabetes
Sang Yeoup Lee, Family Medicine and Biomedical Research Institute, Pusan National Uni versity Yangsan Hospital, Yangsan 50612, South Korea
Sang Yeoup Lee, Medical Education, Pusan National University School of Medicine, Yangsan 50760, South Korea
Author contributions: Lee SY contributed to data collection, study design, data analysis, and interpretation and wrote, read, and approved the final version of the manuscript to be published.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sang Yeoup Lee, Family Medicine and Biomedical Research Institute, Pusan National University Yangsan Hospital, Geumo-ro 20, Mulgeum-eup, Yangsan 50612, South Korea. saylee@pnu.edu
Received: November 25, 2024
Revised: January 20, 2025
Accepted: February 7, 2025
Published online: April 15, 2025
Processing time: 98 Days and 5.5 Hours
Revised: January 20, 2025
Accepted: February 7, 2025
Published online: April 15, 2025
Processing time: 98 Days and 5.5 Hours
Core Tip
Core Tip: This editorial examines jejunoileal side-to-side anastomosis as a novel surgical approach for type 2 diabetes mellitus. It highlights the role of this surgical approach in modulating glucagon-like peptide-1, improving β-cell function, and preserving gastric anatomy, thereby offering a promising alternative for patients with type 2 diabetes mellitus and a relatively high body mass index.